Iannone Robert 4
4 · Jazz Pharmaceuticals plc · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Sale
Ordinary Shares
2025-11-17$168.26/sh−7,159$1,204,573→ 72,628 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.